Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low-grade gliomas: management issues.

Isis Duran1, Jeffrey J Raizer

  • 1Northwestern University, Feinberg School of Medicine, 710 North Lake Shore Drive, Abbott Hall, Department of Neurology, Room 1115, Chicago, IL 60611, USA. iduran004@md.northwestern.edu

Expert Review of Anticancer Therapy
|January 10, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.

medRxiv : the preprint server for health sciences·2026
Same author

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

Neuro-oncology advances·2026
Same author

A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination.

Journal of neuro-oncology·2026
Same author

A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy.

Cancers·2024
Same author

ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2023
Same author

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2022
Same journal

Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine.

Expert review of anticancer therapy·2026
Same journal

Barriers to the use of brachytherapy for treatment of cervical cancer and prostate cancer in low- and middle-income countries.

Expert review of anticancer therapy·2026
Same journal

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

Expert review of anticancer therapy·2026
Same journal

Central nervous system-related permanent consequences in long-term survivors of pediatric Langerhans cell histiocytosis: a clinical overview and monitoring strategies.

Expert review of anticancer therapy·2026
Same journal

RTsDEN: reverse task attention enabled deep learning model for lung cancer detection using computed tomography.

Expert review of anticancer therapy·2026
Same journal

The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinoma.

Expert review of anticancer therapy·2026
See all related articles

Low-grade gliomas are rare brain tumors with unclear optimal management strategies. This review examines current data and challenges in treating these challenging neoplasms.

Area of Science:

  • Neuro-oncology
  • Neurosurgery
  • Neuropathology

Background:

  • Low-grade gliomas represent a rare but complex group of primary brain tumors.
  • Current treatment strategies for low-grade gliomas lack universal consensus, leading to significant clinical debate.

Purpose of the Study:

  • To review existing data on the management of low-grade gliomas.
  • To highlight controversies and challenges in the treatment of these tumors.

Main Methods:

  • Systematic literature review of available data on low-grade glioma management.
  • Analysis of current treatment controversies and unresolved issues.

Main Results:

  • The optimal therapeutic approach for low-grade gliomas remains ill-defined.

Related Experiment Videos

  • Significant controversies persist regarding surgical resection extent, radiation therapy, and chemotherapy.

    • Conclusions:

    • Further research and collaborative efforts are needed to establish standardized management guidelines.
    • Addressing the existing controversies is crucial for improving patient outcomes in low-grade glioma treatment.